Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9771431
SERIAL NO

14350970

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CCAM BIOTHERAPEUTICS LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ben, Moshe Tehila Misgav, IL 5 18
Mandel, Ilana Kiryat Yam, IL 19 26
Markel, Gal Tel Aviv, IL 48 263
Ortenberg, Rona Tel Aviv, IL 11 37
Sapir, Yair Burgata, IL 19 26
Schachter, Jacob Givatayim, IL 15 32

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 26, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 26, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00